Silence Therapeutics Plc (SLN)
6.37
+0.14
(+2.25%)
USD |
NASDAQ |
Dec 19, 16:00
6.33
-0.04
(-0.63%)
After-Hours: 20:00
Silence Therapeutics Market Cap: 300.88M for Dec. 19, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Biodexa Pharmaceuticals Plc | 2.255M |
| Autolus Therapeutics Plc | 433.81M |
| Adaptimmune Therapeutics Plc | 9.409M |
| Mereo BioPharma Group Plc | 318.00M |
| NuCana Plc | 14.82M |
Market Cap Related Metrics
| PS Ratio | 149.42 |
| PEG Ratio | -0.0274 |
| Price to Book Value | 4.062 |
| Price | 6.37 |
| Earnings Yield | -37.35% |
| PEGY Ratio | -0.0274 |